Last Friday Marjory Koller was one of the three finalist competing for the young investigator award at the European Molecular Imaging Meeting 2018 in San Sebastian, Spain. During a plenary session she presented our work entitled: ”Quantitative Fluorescence Endoscopy: a new and promising tool to Predict and Evaluate Response to neoadjuvant chemoradiotherapy in Locally Advanced […]
TRACER will be present at the BIO-Europe Spring in Amsterdam on Monday March 13th and Wednesday March 15th. Marjory Koller will represent TRACER. If you are interested please feel free to contact her on the conference, or already prior to the meeting by email.
The news item ‘Nanosensor That Lights Up Cancer To Be Tested In Surgeries’ was published online Jan 24, 2018. This interesting new technology was developed by scientist at the UT Southwestern Simmons Cancer Center, and TRACER is collaborating in the clinical trial investigating this new technology in the first patients.
We are happy to announce that the paper of the clinical trial in patients with a Barrett’s Oesophagus is published online in the journal Gut, a leading international journal in gastroenterology and hepatology (2016 impact factor: 16.658) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The full […]
Schelto Kruijff received the Young Investigator Grant of the Dutch cancer foundation (KWF) for his project entitled: Precision Thyroid cAncer surgery with intraoperative molecular fluoRescence Guided imaging to rEduce overtreatmenT and postoperative morbidity (TARGET). The project will be executed in close collaboration with OMIG and TRACER Groningen – center of expertise.
Tumor-free surgical margins are critical in breast-conserving surgery, as local recurrence rates increase with positive margins. Molecular imaging is a promising strategy for visualizing and quantifying tumor-specific molecular characteristics and potentially improves breast cancer care in terms of detection, characterization, and (non-)surgical treatment strategies.
This month, our key scientists have reported a pre-clinical study in which the efficacy of photoimmunotherapy of esophageal cancer cell lines was enhanced by priming the cells after induction therapy of the receptor of interest, e.g. EGFR.